Incremental Rise in R&D Spending
Cyprus dedicated €213.6 million to research and development in 2023, amounting to 0.68% of its GDP, according to data released by Cystat. This figure represents a modest 3.2% increase over the previous year, when total expenditure reached €207 million (0.70% of GDP).
Comparative European Landscape
While research and innovation spending in Cyprus has consistently trended upward over the past decade, its relative investment remains below the EU average of 2.26%. Countries such as Malta and Romania exhibit similarly lower percentages, at 0.64% and 0.52% of GDP, respectively, as opposed to the frontrunners like Sweden (3.64%), Belgium (3.27%), and Austria (3.26%) in 2023.
Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram
Long-Term Growth Prospects
Despite its modest share of GDP, Cyprus boasts one of the highest long-term growth rates in its bloc. Between 2000 and 2023, the nation’s R&D expenditure grew at an annual average of 9.96%, and from 2010 to 2023, this growth averaged 7.23%—significantly outpacing the EU’s averages of 4.47% and 4.62% respectively.
Sectoral and Funding Breakdown
Analysis by sector reveals that business enterprises led R&D activity with €89.6 million (41.9% of total expenditure), followed by higher education institutions at €76.9 million (36%), private non-profit organizations at €31.1 million (14.6%), and the government at €16 million (7.5%). Within the corporate sphere, investment was primarily channeled through information and communication companies (accounting for €51.7 million), complemented by pharmaceutical, electronics, and electrical equipment manufacturers, which contributed €25.9 million.
Diversified Funding Sources
Government funds underwrote 23.5% of the total R&D activity, equating to €50.2 million, a slight increase from 22.1% the previous year. Public universities injected €27 million into the ecosystem, while foreign funding, including EU contributions, provided €45.1 million. Notably, the private sector led the financing efforts with a contribution of €91.3 million, representing 42.8% of the aggregate expenditure.
Disciplinary Focus and Human Capital
Research investments were predominantly directed towards the natural sciences (€94.5 million) and engineering and technology (€66.1 million). The social sciences (€22.3 million), agricultural sciences (€12.6 million), medical sciences (€10.5 million), and humanities (€7.5 million) completed the funding profile. The R&D workforce in 2023 edged up slightly, engaging 4,257 personnel overall, including 2,308 full-time equivalent researchers, 39.4% of whom were women, with roughly one-third holding PhD qualifications.
